The effects of booster vaccination of hepatitis B vaccine on anti-HBs negative children 11-15 years after primary vaccination

Human Vaccines

Volumn 7, Issue 10, 2011, Pages

  Yao, Jun ^a   Ren, Jingjing ^a   Shen, Lingzhi ^b   Chen, Yongdi ^a   Liang, Xiaofeng ^c   Cui, Fuqiang ^c   Li, Qian ^a   Jiang, Zhenggang ^a   Wang, Fuzhen ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b NINGBO UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Anti HBs; Booster vaccination; Effect; Hepatitis B vaccine made by recombinant deoxyribonucleic acid (DNA) techniques in Chinese hamster ovary (CHO) cells; HepB (CHO)

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEROCONVERSION; VACCINATION;

EID: 80054738365     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350:1118-29. (Pubitemid 38298992)
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat 2004; 11:97-107. (Pubitemid 38365759)
3. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34:1329-39. (Pubitemid 41819540)
4. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China - declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27:6550-7.
5. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009; 200:39-47.
6. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl) 2009; 122:3-4.
7. Chang MH, Hadzic D, Rouassant SH, Jonas M, Kohn IJ, Negro F, et al. Acute and chronic hepatitis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39:584-8.
8. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, et al. [A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old]. Zhonghua Liu Xing Bing Xue Za Zhi 2005; 26:655-8.
9. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999; 179:489-92. (Pubitemid 29086654)
10. Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379-84. (Pubitemid 41443405)
11. Kato H, Nakata K, Hamasaki K, Hida D, Ishikawa H, Aritomi T, et al. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction. Vaccine 1999; 18:581-7. (Pubitemid 29509840)
12. Coursaget P, Leboulleux D, Soumare M, le Cann P, Yvonnet B, Chiron JP, et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 1994; 21:250-4. (Pubitemid 24270554)
13. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30:1312-7.
14. Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999; 179:1319-25. (Pubitemid 29246578)
15. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 1999; 17:2946-50. (Pubitemid 29366973)
16. Wang LY, Hu CT, Ho TY, Lin HH. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine 2006; 24:4427-32.
17. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, et al. Hepatitis B virus infection in adolescents in a rural township - 15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006; 24:759-65. (Pubitemid 43190082)
18. Wang JJ, Yan TQ, Li QS, Wen ZL, Xia GL, Liu CB. Study on Immune Persistence of Hepatitis B Vaccine in Newborns and the Immune Response of Boosting. China Planning Immunization 2002; 8:185-8.
19. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-41. (Pubitemid 40293406)
20. van der Sande MA, Waight PA, Mendy M, et al. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. J PLoS One 2007; 2:753.
21. McMahon BJ, Dentinger CM, Bruden D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200:1390-6.
22. Hepatitis B vaccines WHO position paper 2009 [OL] http://www.who.int/ immunization/documents/positionpapers/en/index.html
23. Van Damme P, Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. J Travel Med Infect Dis 2007; 5:79-84. (Pubitemid 46211211)
24. Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. J Vaccine 2010; 28:730-6.
25. Chaves SS, Groeger J, Helgenberger L, et al. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. J Vaccine 2010; 28:2860-4.
26. Petersen KM, Bulkow LR, McMahon BJ, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. J Pediatr Infect Dis J 2004; 23:650-5. (Pubitemid 38924890)
27. Lee SS, Young BW, Wong KH, et al. The implication of a reduced-dose hepatitis B vaccination schedule in low risk newborns. J Vaccine 2002; 20:3752-4. (Pubitemid 35229997)
28. Bialek SR, Bower WA, Novak R, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. J Pediatr Infect Dis J 2008; 27:881-5.
29. Wang LY, Lin HH. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago. J vaccine 2007; 25:7160-7.
30. Lu CY, Chiang BL, Chi WK, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. J Hepatology 2004; 40:1415-20.